# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Moderna shares are up almost 29% this month; CureVac is up 72% in the past month; and Novavax spiked 317% in the past month.
Novavax (NASDAQ: NVAX) stock surges on positive COVID-19 vaccine news, with FDA setting a PDUFA review date for April 2025. Hig...
The FDA's committee of independent advisors voted unanimously on Wednesday to recommend that the FDA tell vaccine makers t...
The company also mentioned that it anticipates commercial delivery of the protein-based vaccine in the U.S. in September, pendi...
FRGT: 115% | Freight Technologies Says It Added 26 New Customers And 149 New Carriers In 2024 NVAX: 30% | Novavax shares are t...
- Bloomberg
- Bloomberg